Reference
Trussell J, et al. Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception. Contraception : 24 Jan 2014. Available from: URL: http://dx.doi.org/10.1016/j.contraception.2013.10.019
Additional information
* The study was funded by Bayer Healthcare Pharmaceuticals Inc.
Rights and permissions
About this article
Cite this article
LNG-IUS more effective contraceptive at lower cost. PharmacoEcon Outcomes News 698, 7 (2014). https://doi.org/10.1007/s40274-014-1107-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1107-5